Peripherally inserted central catheters are commonly known as percutaneous indwelling central catheters or PICC line.
Global Neonatal Peripherally Inserted Central Venous Catheters Market: Introduction
Peripherally inserted central catheters (PICC) are commonly known as percutaneous indwelling central catheters or PICC line. PICC lines are often used in antibiotic therapy, chemotherapy, or total parenteral nutrition or for administration of drugs that should not be given peripherally. PICC line is inserted in the body percutaneously at peripheral site and extended up to superior vena cava. It is an alternative to central venous catheter, which is inserted through major veins such as jugular or femoral.
Read Report Overview - https://www.transparencymarketresearch.com/neonatal-peripherally-inserted-central-venous-catheter-market.html
Generally, PICC line is appropriate for patients who have undergone more than two weeks of treatment. These catheters are well sustained by neonates, with dwell time of two to three weeks. However, dwell time varies case to case. There could be risk of complications such as phlebitis, bleeding, and catheter occlusion due to holding of PICC for more than a month. Strict infection control procedures should be followed before insertion of PICC line to reduce the risk of infection.
Several global manufacturers plan to introduce innovative and technologically advanced products in the market. These innovations present numerous opportunities in the global neonatal peripherally inserted central venous catheters market, offering easy use of vascular access devices associated with increasing patient safety. Vygon S.A. provides a range of advanced polyurethane PICC catheters such as Premicath injectable catheters, Nutriline, and Premistar. Pregnancy complications such as multiple births are associated with an increased risk of preterm delivery, low birth weight, and other associated high-risk morbidities. This increases demand for NICU services.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=45516
ewborn infections and birth asphyxia account for over 80% of all global neonatal deaths. This has created a need of early diagnosis and appropriate treatment in hospitals, which in turn has increased NICU admissions. These factors contribute to the growth of the global neonatal peripherally inserted central venous catheters market. Safer and advanced catheter insertion systems and availability of trained technicians due to rise in adoption of PICC line are expected to fuel the growth of the global market. The cost of vascular access device and its maintenance forms a crucial economic factor in the long-term management of complications. Neonatal intensive care is extremely expensive, causing financial burden on both the family and the health care system.
Key Drivers of Global Neonatal Peripherally Inserted Central Venous Catheters Market
Increase in Incidence of Neonatal Illnesses
According to the World Health Organization, every year, nearly 41% of all under-five child deaths are among newborn infants, babies in their first 28 days of life or the neonatal period. The risk of death of a baby in the first four weeks of life is nearly 15 times greater than any other time before his or her one year of birth. About 8.2 million under-five child deaths per year, about 3.3 million occur during the neonatal period in the first four weeks of life.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=45516
Rise in Cases of Preterm Birth due to Premature Rupture of Membrane
Premature rupture of membrane (PROM) is rupture of the membrane (amniotic sac) before labor begins. If PROM occurs before 37 weeks of pregnancy, it is called preterm premature rupture of membrane (PPROM). PROM occurs in about 8% to 10% of all pregnancies. The incidence of premature rupture of membrane ranges from about 5% to 10% of all deliveries.
North America to Account for Major Share of Global Neonatal Peripherally Inserted Central Venous Catheters Market
- North America is projected to account for major share of the global neonatal peripherally inserted central venous catheters market during the forecast period. The market in the region is anticipated to grow at a rapid pace in the next few years due to increase in research & development and technologically advanced products being introduced in the market. Europe is expected to be the second largest market during the forecast period owing to advanced facilities provided by hospitals in the region.
- The neonatal peripherally inserted central venous catheters market in Asia Pacific is likely to expand at a high CAGR during the forecast period owing to the large population and high birthrate.
Pre Book Neonatal Peripherally Inserted Central Venous Catheters Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=45516<ype=S
Key Players Operating in Global Neonatal Peripherally Inserted Central Venous Catheters Market
The global neonatal peripherally inserted central venous catheters market is highly consolidated owing to the presence of small number of key players. Leading players operating in the global neonatal peripherally inserted central venous catheters market include:
- C. R. Bard Inc.
- Argon Medical
- Teleflex Included
- Medical Parts, Inc.
- Vygon S.A.
- AngioDynamics, Inc.
- Vitality Medical
- B. Braun
- Coloplast
- Boston Scientific Company
- Koninklijke Philips N.V
- Abbott
- Medtronic plc
- Braun Melsungen Ag
- Becton, Dickinson and Company
- Terumo Medical Company
- Covidien AG
- ACIST Medical Programs
- Getinge AB
- Biotronic SE & CO.KG
- Biosense Webster, Inc.
- Cordis
- QX Medical
Browse More Trending by Transparency Market Research:
Oncology Small Molecule Drugs Market: https://www.transparencymarketresearch.com/oncology-small-molecule-drugs-market.html
Protein A Resin Market: https://www.transparencymarketresearch.com/protein-a-resin-market.html
Injectable Benzodiazepine Market: https://www.transparencymarketresearch.com/injectable-benzodiazepine-market.html
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/